SCHEMBL1574056

SCHEMBL1574056

[CH2]Sc1nnnn1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4671778 0.79 ALDH1A1 (0.62)
SCHEMBL1235535 0.77
SCHEMBL11116673 0.75
SCHEMBL2985000 0.75
SCHEMBL10974031 0.73 ALDH1A1 (0.75)
SCHEMBL10914858 0.73 ALDH1A1 (0.56)
SCHEMBL10970972 0.73 ALDH1A1 (0.67)
SCHEMBL10969480 0.73 ALDH1A1 (0.67)
SCHEMBL10975385 0.73 ALDH1A1 (0.67)
SCHEMBL11689701 0.72 KMT2A (0.53)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 276 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9026372-B2 Methods for providing a system of care for a high-dose oxazaphosphorine drug regimen ACCENTIA BIOPHARMACEUTICALS, INC. (US) 2015-05-05 US claimed
US-20110117050-A1 Methods for Providing a System of Care for an Oxazaphosphorine Drug Regimen ACCENTIA BIOPHARMACEUTICALS, INC. (US) 2011-05-19 US claimed
US-20110097426-A1 Methods for Safe and Effective Treatment Using Oxazaphosphorine Drugs ACCENTIA BIOPHARMACEUTICALS, INC. (US) 2011-04-28 US claimed
US-20110082115-A1 Methods for Providing a System of Care for an Oxazaphosphorine Drug Regimen ACCENTIA BIOPHARMACEUTICALS, INC. (US) 2011-04-07 US claimed
WO-2009067690-A2 METHODS FOR SAFE AND EFFECTIVE TREATMENT USING OXAZAPHOSPHORINE DRUGS ACCENTIA BIOPHARMACEUTICALS, INC. (US) 2009-05-28 WO claimed
WO-2009067699-A2 METHODS FOR PROVIDING A SYSTEM OF CARE FOR AN OXAZAPHOSPHORINE DRUG REGIMEN ACCENTIA BIOPHARMACEUTICALS, INC. (US) 2009-05-28 WO claimed
US-20070060558-A1 Hybrid molecules QA where Q is an aminoquinoline and A is an antibiotic residue, the synthesis and uses thereof as antibacterial agents PALUMED S.A. (FR) 2007-03-15 US claimed
EP-1212055-A4 NEUROTHERAPEUTIC COMPOSITION AND METHOD REVAAX PHARMACEUTICALS LLC (US) 2005-09-07 EP claimed
US-20030036541-A1 Beta-lactamase inhibiting compounds RESEARCH CORPORATION TECHNOLOGIES, INC. 2003-02-20 US claimed
JP-2003506490-A 2003-02-18 JP claimed
EP-0031708-A2 Cephalosporin derivatives, processes for their manufacture, pharmaceutical compositions containing them and intermediates therefor ICI PHARMA (FR) 1981-07-08 EP claimed
US-4267176-A Amino or acylamino-substituted pyrimidinyl cephalosporanic acid derivatives and pharmaceutical compositions thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-05-12 US claimed
US-4251657-A Method for removing protective groups TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1981-02-17 US claimed
US-4200747-A 7-2-Indolyl acetamido cephalosporin derivatives YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 1980-04-29 US claimed
EP-0002586-A1 Method for removing a halogenoacetyl protective group from a halogenoacetyl amino compound Takeda Chemical Industries, Ltd. (JP) 1979-06-27 EP claimed
US-4068071-A DISULFIDING, SOLVOLYSIS TAKEDA CHEMICAL INDUSTRIES, LTD. (JA) 1978-01-10 US claimed
US-4068072-A CHLORINATION OR BROMINATION, SOLVOLYSIS TAKEDA CHEMICAL INDUSTRIES, LTD. (JA) 1978-01-10 US claimed
US-4067979-A Cephalosporins having an α-acyloxyacetic acid side chain CIBA-GEIGY CORPORATION (US) 1978-01-10 US claimed
US-4048155-A OXIDATION OF 7-BENZYLIDENEAMINO DERIVATIVE, REACTION WITH ALCOHOL SANKYO COMPANY LIMITED (JA) 1977-09-13 US claimed
US-4016155-A Process for preparing cephalosporin derivatives SANKYO COMPANY LIMITED (JA) 1977-04-05 US claimed